Wonbiogen Co., Ltd. (KOSDAQ: 307280)
South Korea
· Delayed Price · Currency is KRW
1,355.00
-15.00 (-1.09%)
Sep 11, 2024, 3:00 PM KST
Wonbiogen Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
Sep '24 Sep 10, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Market Capitalization | 48,066 | 60,375 | 58,397 | 74,002 | - |
Market Cap Growth | -35.33% | 3.39% | -21.09% | - | - |
Enterprise Value | 42,558 | 60,117 | 59,424 | 68,665 | - |
Last Close Price | 1355.00 | 1702.00 | 1649.51 | 1993.12 | - |
PE Ratio | 11.12 | 11.74 | 18.53 | -94.91 | - |
PS Ratio | 1.63 | 2.04 | 2.18 | 4.18 | - |
PB Ratio | 1.40 | 1.85 | 2.18 | 2.79 | - |
P/FCF Ratio | 10.66 | 18.93 | -82.02 | -59.01 | - |
P/OCF Ratio | 9.17 | 12.49 | 10.10 | 68.39 | - |
EV/Sales Ratio | 1.45 | 2.03 | 2.22 | 3.87 | - |
EV/EBITDA Ratio | 5.30 | 6.98 | 9.51 | 23.51 | - |
EV/EBIT Ratio | 6.66 | 8.54 | 11.77 | 33.66 | - |
EV/FCF Ratio | 9.44 | 18.85 | -83.47 | -54.76 | - |
Debt / Equity Ratio | 0.19 | 0.22 | 0.34 | 0.30 | -3.70 |
Debt / EBITDA Ratio | 0.82 | 0.85 | 1.47 | 2.77 | 0.83 |
Debt / FCF Ratio | 1.48 | 2.29 | -12.92 | -6.45 | 22.63 |
Asset Turnover | 0.67 | 0.72 | 0.69 | 0.62 | - |
Inventory Turnover | 2.48 | 2.40 | 2.66 | 2.96 | - |
Quick Ratio | 1.98 | 1.45 | 1.03 | 1.61 | 0.29 |
Current Ratio | 2.74 | 2.26 | 1.57 | 2.10 | 0.42 |
Return on Equity (ROE) | 14.76% | 20.05% | 12.26% | -5.11% | - |
Return on Assets (ROA) | 9.19% | 10.75% | 8.20% | 4.45% | - |
Return on Capital (ROIC) | 9.88% | 11.58% | 8.93% | 6.96% | - |
Earnings Yield | 8.99% | 9.11% | 5.49% | -0.97% | - |
FCF Yield | 9.38% | 5.28% | -1.22% | -1.69% | - |
Dividend Yield | 1.46% | 1.18% | 0.61% | - | - |
Payout Ratio | 15.55% | 6.36% | - | - | - |
Buyback Yield / Dilution | 0.03% | -5.70% | -3.58% | -49.52% | - |
Total Shareholder Return | 1.49% | -4.52% | -2.97% | -49.52% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.